BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36203245)

  • 1. Venous thromboembolism risk after spinal cord injury: A secondary analysis of the CLOTT study.
    Godat LN; Haut ER; Moore EE; Knudson MM; Costantini TW
    J Trauma Acute Care Surg; 2023 Jan; 94(1):23-29. PubMed ID: 36203245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early venous thromboembolism prophylaxis in patients with trauma intracranial hemorrhage: Analysis of the prospective multicenter Consortium of Leaders in Traumatic Thromboembolism study.
    Wu YT; Chien CY; Matsushima K; Schellenberg M; Inaba K; Moore EE; Sauaia A; Knudson MM; Martin MJ;
    J Trauma Acute Care Surg; 2023 Nov; 95(5):649-656. PubMed ID: 37314427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and comparative efficacy of initiating low-molecular-weight heparin within 24 hours of injury or surgery for venous thromboembolism prophylaxis in patients with spinal cord injury: a prospective TRACK-SCI registry study.
    Lui A; Park C; Chryssikos T; Radabaugh H; Patel A; Aabedi AA; Ferguson AR; Torres Espin A; Mummaneni PV; Dhall SS; Duong-Fernandez X; Saigal R; Chou A; Pan J; Singh V; Hemmerle DD; Kyritsis N; Talbott JF; Pascual LU; Huie JR; Whetstone WD; Bresnahan JC; Beattie MS; Weinstein PR; Manley GT; DiGiorgio AM
    Neurosurg Focus; 2023 Oct; 55(4):E17. PubMed ID: 37778033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enoxaparin versus tinzaparin for venous thromboembolic prophylaxis during rehabilitation after acute spinal cord injury: a retrospective cohort study comparing safety and efficacy.
    Marciniak CM; Kaplan J; Welty L; Chen D
    PM R; 2012 Jan; 4(1):11-7. PubMed ID: 22269449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.
    Gritsiouk Y; Hegsted DA; Schlesinger P; Gardiner SK; Gubler KD
    Am J Surg; 2014 May; 207(5):648-51; discussion 651-2. PubMed ID: 24560359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population.
    Khaldi A; Helo N; Schneck MJ; Origitano TC
    J Neurosurg; 2011 Jan; 114(1):40-6. PubMed ID: 20815694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin versus enoxaparin for prevention of venous thromboembolism after trauma: A randomized noninferiority trial.
    Olson EJ; Bandle J; Calvo RY; Shackford SR; Dunne CE; Van Gent JM; Zander AL; Sikand H; Bongiovanni MS; Sise MJ; Sise CB
    J Trauma Acute Care Surg; 2015 Dec; 79(6):961-8; discussion 968-9. PubMed ID: 26317819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does tranexamic acid increase venous thromboembolism risk among trauma patients? A prospective multicenter analysis across 17 level I trauma centers.
    Knowlton LM; Arnow K; Trickey AW; Sauaia A; Knudson MM
    Injury; 2023 Nov; 54(11):111008. PubMed ID: 37669883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective Evaluation of Venous Thromboembolism Prophylaxis in Elderly, High-Risk Trauma Patients.
    Krantz EN; Philpott CD; Droege ME; Mueller EW; Ernst NE; Garber PM; Tsuei BJ; Goodman MD; Droege CA
    J Surg Res; 2020 May; 249():225-231. PubMed ID: 31991331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of heparin therapy for preventing venous thromboembolism in acute spinal cord injury.
    Liu Y; Xu H; Liu F; Lv Z; Kan S; Ning G; Feng S
    Int J Surg; 2017 Jul; 43():94-100. PubMed ID: 28579397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potentially expanded role for enoxaparin in preventing venous thromboembolism in high risk blunt trauma patients.
    Norwood SH; McAuley CE; Berne JD; Vallina VL; Kerns DB; Grahm TW; McLarty JW
    J Am Coll Surg; 2001 Feb; 192(2):161-7. PubMed ID: 11220715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unfractionated heparin versus enoxaparin for venous thromboembolism prophylaxis in intensive care units: a propensity score adjusted analysis.
    Samuel S; Li W; Dunn K; Cortes J; Nguyen T; Moussa D; Kumar A; Dao T; Beeson J; Choi HA; McCullough LD
    J Thromb Thrombolysis; 2023 May; 55(4):617-625. PubMed ID: 37029256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and effectiveness of early chemical deep venous thrombosis prophylaxis after spinal cord injury: pilot prospective data.
    DiGiorgio AM; Tsolinas R; Alazzeh M; Haefeli J; Talbott JF; Ferguson AR; Bresnahan JC; Beattie MS; Manley GT; Whetstone WD; Mummaneni PV; Dhall SS
    Neurosurg Focus; 2017 Nov; 43(5):E21. PubMed ID: 29088948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.
    Jacobs BN; Cain-Nielsen AH; Jakubus JL; Mikhail JN; Fath JJ; Regenbogen SE; Hemmila MR
    J Trauma Acute Care Surg; 2017 Jul; 83(1):151-158. PubMed ID: 28426561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Risk of Symptomatic Venous Thromboembolism After Surgery for Spine Metastatic Bone Lesions: A Retrospective Study.
    Groot OQ; Ogink PT; Paulino Pereira NR; Ferrone ML; Harris MB; Lozano-Calderon SA; Schoenfeld AJ; Schwab JH
    Clin Orthop Relat Res; 2019 Jul; 477(7):1674-1686. PubMed ID: 31135550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal Timing of Initiation of Thromboprophylaxis after Nonoperative Blunt Spinal Trauma: A Propensity-Matched Analysis.
    Khan M; Jehan F; O'Keeffe T; Hamidi M; Truitt M; Zeeshan M; Gries L; Tang A; Joseph B
    J Am Coll Surg; 2018 May; 226(5):760-768. PubMed ID: 29382561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
    Reeves D; Liu CY
    J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors for venous thromboembolism in patients with acute spinal cord injury: A retrospective study.
    Piran S; Schulman S
    Thromb Res; 2016 Nov; 147():97-101. PubMed ID: 27721141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dalteparin vs low-dose unfractionated heparin for prophylaxis against clinically evident venous thromboembolism in acute traumatic spinal cord injury: a retrospective cohort study.
    Worley S; Short C; Pike J; Anderson D; Douglas JA; Thompson K
    J Spinal Cord Med; 2008; 31(4):379-87. PubMed ID: 18959355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dalteparin versus enoxaparin for venous thromboembolism prophylaxis in acute spinal cord injury and major orthopedic trauma patients: 'DETECT' trial.
    Slavik RS; Chan E; Gorman SK; de Lemos J; Chittock D; Simons RK; Wing PC; Ho SG
    J Trauma; 2007 May; 62(5):1075-81; discussion 1081. PubMed ID: 17495705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.